Company to showcase the Melzi Sharps Finder, a U.S. FDA registered device designed to locate lost needles and objects for…
Initial Draw of $20 Million to Support Funding Phase 3 Development of Vurolenatide in Short Bowel SyndromeRALEIGH, NC / ACCESSWIRE…
TORTOLA, BVI / ACCESSWIRE / June 30, 2022 / Enlighta Inc. (TSXV:NLTA) ("Enlighta" or the "Company") is pleased to announce…
Investors, Analysts, and Advisors Invited to Attend this Real-Time, Interactive Presentation/Q&A EventSOUTH EASTON, MA / ACCESSWIRE / June 30, 2022…
SphingoTec appoints Jörg Menten as Chief Executive Officer (CEO) as from July 1, 2022 to drive the commercialization and scale…
Phase 2 VIBRANT study identifies a dose and dosing interval with >25% improvement in the primary endpoint of 24-hour mean…
Lung Cancer Orchestrator June 30, 2022Solution adds proteomic analysis of blood-based biomarkers to Philips Lung Cancer Orchestrator to better assess…
Cris Ewell recognized by second-annual C100 awards for outstanding achievements in the cybersecurity communityLINCOLN, Neb., June 30, 2022 (GLOBE NEWSWIRE)…
SAN FRANCISCO, June 30, 2022 (GLOBE NEWSWIRE) -- Headlands Research announced today the acquisition of Peninsula Research Associates (PRA) of…
ANAHEIM, CA, June 30, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of…